Efficacy and safety of IV ferumoxytol for iron deficiency anemia in patients with cancer

PURPOSE: Iron deficiency anemia (IDA) is common in cancer patients due to blood loss and inflammation. Many do not tolerate oral iron or adequately respond. Intravenous (IV) iron is commonly used as an adjunct to erythropoiesis-stimulating agents; data on the use of IV iron monotherapy in these pati...

Descripción completa

Detalles Bibliográficos
Autores principales: Vadhan-Raj, Saroj, Dahl, Naomi V, Bernard, Kristine, Li, Zhu, Strauss, William E
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2017
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5724711/
https://www.ncbi.nlm.nih.gov/pubmed/29263710
http://dx.doi.org/10.2147/JBM.S138474

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5724711/
https://www.ncbi.nlm.nih.gov/pubmed/29263710
http://dx.doi.org/10.2147/JBM.S138474

Ejemplares similares